Monte Rosa Therapeutics Inc.

GLUE | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.54

+$0.28 (+2.28%)

Sep 22, 2026, 9:49 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Cash & Equivalents	90.1M	159.86M	129.88M	208.34M	69.43M	78.53M	224.25M	125.58M	108.85M	99.75M	128.1M	59.06M	47.03M	51.85M	54.91M	112.39M	103.66M	138.31M	346.07M	367.03M	357.06M	168.44M
Short-Term Investments	531M	506.36M	247.22M	182.92M	221.17M	247.54M	147.9M	116.61M	153.36M	93.14M	104.31M	119.42M	156.04M	179.89M	207.91M	159.76M	190.48M	178.86M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	4.95M	n/a	n/a	4.91M	4.87M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.34M	n/a	n/a	1.16M
Other Long-Term Assets	5.77M	5.78M	5.1M	5.36M	445K	5.32M	4.98M	159K	209K	5.25M	4.93M	4.79M	4.82M	4.67M	4.6M	4.45M	5.7M	5.33M	n/a	1.73M	1.73M	n/a
Receivables	9.84M	4.61M	4.6M	4.97M	2.37M	1.41M	173K	595K	9.84M	601K	505K	294K	1.15M	2.17M	7.66M	17.56M	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	5.38M	6.72M	11.48M	5.59M	6.5M	4.8M	5.12M	8.43M	5.85M	5.54M	3.29M	4.14M	3.88M	6.65M	5.4M	960K	n/a	n/a	2.6M	n/a	40K	79K
Total Current Assets	636.33M	677.55M	393.19M	401.82M	299.47M	332.28M	377.44M	251.21M	277.9M	199.04M	236.21M	182.91M	208.1M	240.56M	275.89M	295.24M	297.05M	320.37M	348.67M	370.52M	358.29M	171.71M
Property-Plant & Equipment	53.99M	53.1M	50.37M	52.66M	54.73M	55.6M	56.31M	58.81M	61.14M	62.46M	62.61M	64.4M	65.69M	63.8M	61.91M	57.92M	62.31M	20.31M	12.33M	11.8M	8.92M	7.73M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	59.76M	58.88M	55.47M	58.02M	60.12M	60.92M	61.29M	63.87M	66.22M	67.71M	67.54M	69.19M	70.51M	68.47M	66.5M	62.37M	68.01M	25.64M	17.66M	13.53M	10.65M	8.9M
Total Assets	696.08M	736.43M	448.66M	459.84M	359.59M	393.2M	438.73M	315.08M	344.11M	266.75M	303.76M	252.1M	278.62M	309.03M	342.39M	357.6M	365.06M	346.01M	366.33M	384.05M	368.94M	180.6M
Account Payables	7.15M	7.9M	3.55M	14.51M	5.58M	6.49M	17.22M	3.98M	6.47M	6.83M	11.15M	5.5M	5.31M	7.38M	7.86M	9.75M	4.29M	4.51M	6.56M	3.53M	7.46M	7.33M
Deferred Revenue	22.1M	33.06M	29.57M	24.79M	18.41M	32.58M	117.23M	18.92M	19.65M	20.41M	17.68M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	4.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	32.93M	6.28M	11.58M	8.91M	8.64M	8.26M	11.57M	8.01M	7.62M	5.7M	9.26M	9.05M	6.92M	7.01M	10.64M	n/a	n/a	n/a	840K	n/a	n/a	1.77M
Total Current Liabilities	66.81M	71.04M	64.21M	61.44M	41.85M	59.22M	156.95M	41.64M	42.35M	41.29M	46.59M	22.61M	19.09M	20.52M	25.57M	21.79M	14.77M	12.49M	16.64M	12.74M	10.79M	9.09M
Long-Term Debt	33.36M	34.58M	34.79M	35.93M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	231.17M
Other Long-Term Liabilities	110.87M	108.9M	5.27M	116.63M	4.56M	3.96M	3.7M	2.82M	2.61M	2.57M	2.71M	1.45M	1.51M	1.51M	1.53M	2.13M	2.14M	2.18M	2.18M	2M	1.47M	n/a
Total Long-Term Liabilities	144.22M	143.48M	151.39M	152.56M	49.65M	58.82M	58.85M	67.98M	77.1M	72.93M	77.91M	44.97M	45.87M	44.79M	45.41M	44.72M	48.23M	7.64M	2.18M	2M	1.47M	232.13M
Total Liabilities	211.03M	214.51M	215.6M	214M	91.51M	118.04M	215.8M	109.62M	119.44M	114.23M	124.51M	67.58M	64.96M	65.3M	70.98M	66.51M	63.01M	20.13M	18.81M	14.74M	12.26M	241.22M
Total Debt	37.99M	39.06M	39.19M	40.17M	41.13M	41.86M	42.72M	43.7M	44.36M	45.18M	46.04M	46.4M	47.04M	46.17M	47M	45.66M	48.76M	6.98M	n/a	n/a	n/a	231.17M
Book Value	485.05M	521.92M	233.06M	245.84M	268.08M	275.16M	222.94M	205.46M	224.67M	152.52M	179.25M	184.52M	213.65M	243.73M	271.41M	291.09M	302.05M	325.88M	347.52M	369.31M	356.68M	-60.62M
Book Value Per Share	4.78	7.96	3.56	2.98	3.26	3.32	3.63	2.51	3.15	2.54	3.15	3.70	4.32	4.94	5.55	6.23	6.47	6.99	7.56	8.03	7.76	-1.42
Common Stock	9K	8K	7K	6K	6K	6K	6K	6K	6K	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K	4K	1K
Retained Earnings	-565.11M	-521.72M	-477.21M	-431.08M	-404M	-391.7M	-438.59M	-452.03M	-428.17M	-397.86M	-365.89M	-332.64M	-297.75M	-262.57M	-230.54M	-199.75M	-172.44M	-145.97M	-122.04M	-98.6M	-78.76M	-60.35M
Comprehensive Income	-5.17M	-4.75M	-3.83M	-3.25M	-3.37M	-3.33M	-3.36M	-2.32M	-2.67M	-2.69M	-2.72M	-1.46M	-1.64M	-1.39M	-1.75M	-2.6M	-2.46M	-2.13M	-2.02M	-1.95M	-1.42M	-920K
Shareholders Equity	487.28M	521.92M	233.06M	245.84M	268.08M	275.16M	222.94M	205.46M	224.67M	152.52M	179.25M	184.52M	213.65M	243.73M	271.41M	291.09M	302.05M	325.88M	347.52M	369.31M	356.68M	-60.62M
Total Investments	531M	506.36M	247.22M	182.92M	226.12M	247.54M	147.9M	121.52M	158.22M	93.14M	104.31M	119.42M	156.04M	179.89M	207.91M	159.76M	190.48M	178.86M	5.34M	n/a	n/a	1.16M